DEXTROSE (Cardinal Health)


Welcome to the PulseAid listing for the DEXTROSE drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: DEXTROSE MONOHYDRATE
SUBSTANCE NAME: DEXTROSE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1971-03-04
END MARKETING DATE: 0000-00-00


DEXTROSE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDEXTROSE from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 50(g/1000mL)
START MARKETING DATE: 1971-03-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-2885_c2f71fb0-3ae6-4fe2-8bd3-d40ffcab2a58
PRODUCT NDC: 55154-2885
APPLICATION NUMBER: NDA016673

Other DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Dextrose
Baxter Healthcare CorporationDEXTROSE
Becton Dickinson and CompanyDextrose
Cardinal HealthDEXTROSE
Fresenius Kabi USA, LLCDextrose
General Injectables & Vaccines, IncDextrose
General Injectables & Vaccines, Inc.Dextrose
Hospira, Inc.Dextrose
International Medication Systems, LimitedDextrose Monohydrate
Physicians Total Care, Inc.Dextrose